Genetically Engineered Extracellular Vesicles Harboring Transmembrane Scaffolds Exhibit Differences in Their Size, Expression Levels of Specific Surface Markers and Cell-Uptake.

导出 OA

翻译打印收藏纠错

作者： Jiayi,Zhang ^[1] ; Annie,Brown ^[1] ; Brendan,Johnson ^[1] ; David,Diebold ^[1] ; Kyle,Asano ^[1] ; Gerard,Marriott ^[2] ; Biao,Lu ^[1]

作者单位： Department of Bioengineering, School of Engineering, Santa Clara University, 500 El Camino Real, Santa Clara, CA 95053, USA. ^[1] Department of Bioengineering, University of California at Berkeley, Berkeley, CA 94720, USA. ^[2]

关键词 CD63 CD81 CD9 exosome extracellular vesicles (EVs)nanotechnology targeted drug delivery vesicular stomatitis virus envelope glycoprotein (VSVG)

DOI 10.3390/pharmaceutics14122564

PMID 36559058

发布时间 2022-12-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pharmaceutics

2022年14卷12期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Genetically Engineered Extracellular Vesicles Harboring Transmembrane Scaffolds Exhibit Differences in Their Size, Expression Levels of Specific Surface Markers and Cell-Uptake.

Pharmaceutics

相似文献

Pharmaceutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Genetically Engineered Extracellular Vesicles Harboring Transmembrane Scaffolds Exhibit Differences in Their Size, Expression Levels of Specific Surface Markers and Cell-Uptake.

Pharmaceutics

相似文献

Pharmaceutics

相关期刊

检索历史清除